MedPath
HSA Approval

SHINCEF FOR INJECTION 1.5 g/ vial

SIN10947P

SHINCEF FOR INJECTION 1.5 g/ vial

SHINCEF FOR INJECTION 1.5 g/ vial

May 25, 1999

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01DC02

cefuroxime

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

CEFUROXIME SODIUM

1.5 g/ vial

Cefuroxime

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SHINCEF FOR INJECTION 1.5 g/ vial - HSA Approval | MedPath